| |
|
|
|
| contraindicated in myasthenia gravis; use with caution in renal insufficiency. PREECLAMPSIAused extensively in Europe; may be used in myasthenia gravis … |
|
|
|
|
| Myasthenia Gravis. Post-synaptic receptor site disorder. Myasthenia Syndrome. Pre-synaptic calcium channel disorder. Lambert-Eaton Syndrome; Botulism … |
|
|
|
|
| Myasthenia gravis. Crohn’s disease. Grave’s disease. Type 1 Diabetes mellitus. Rheumatoid arthritis. Psoriasis. Scleroderma. Systemic lupus erythematosus … |
|
|
|
|
| Stroke – present in up to 47%; Amyotrophic Lateral Sclerosis; Parkinson’s Disease; Multiple Sclerosis; Muscular Dystrophy; Myasthenia Gravis … |
|
|
|
|
| 55 year-old man with myasthenia gravis presents to the ED with 24 hours of47 year-old woman with myasthenia gravis and chronic renal insufficiency … |
|
|
|
|
| Myasthenia Gravis. Fatigability; Double vision; Lid twitch; Ptosis; Normal reflexes & sensation. INVESTIGATIONS MG. Anti ACh receptor Ab’s; Electromyography … |
|
|
|
|
| Poliomyelitis, Guillain-Barre syndrome, ALS, myasthenia gravis, muscular dystrophies. All these lead to dyspnea and respiratory failure. … |
|
|
|
|
| Incomplete resection; Absence of myasthenia gravis; Advanced pathologic stageComplete resection; Presence of myasthenia gravis; Early pathologic stage … |
|
|
|
|
| Neuromuscular junctionMyasthenia gravis. Myasthenia gravisMyasthenia gravisanesthesia. Reversal drugs may have unpredictable effects … |
|
|
|
|
| Myasthenia gravis. Requirement vary but usually are about 50% normal. Burn patients. ResistanceMyasthenia gravis-not recommended. Rocuronium … |
|
|
